In a recent study, researchers at Fox Chase Cancer Center demonstrated how amplification and rearrangement of a gene associated with leukemia known as MLL is directly controlled by epigenetic factors, providing needed insights into a new therapeutic opportunity.
Each year, a few hundred people tackle the eight-day journey down the wild Tasmanian rafting river. For former blockaders who helped prevent it being dammed, the trip has added poignancy